/Investor DB

WUTIF Capital — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Naegis Pharmaceuticals Inc.naegispharma.comApr 2024

Naegis Pharmaceuticals is a drug discovery and development company creating first-in-class small-molecule treatments for serious ophthalmic and inflammatory diseases.

BiotechHealthtechMedical DevicesVancouver

Alan Ridgeway(Chief Executive Officer)inEduardo Navajas(Chief Medical Officer)Philip Davies(Director)Michael Liggett(Director)Julian Gangolli(Director)Cameron Groome(Director)

PartnerMike Volker· solo GP

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.